{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:49:46Z","timestamp":1791265786233,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T00:00:00Z","timestamp":1492560000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s12072-017-9796-z","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T01:48:38Z","timestamp":1492566518000},"page":"286-291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-significant and significant fibrosis in patients with chronic hepatitis C"],"prefix":"10.1007","volume":"11","author":[{"given":"G.","family":"Shiha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Seif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Eldesoky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Elbasiony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Metwally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Zalata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mikhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,19]]},"reference":[{"key":"9796_CR1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/hep.23315","volume":"51","author":"JE Everhart","year":"2010","unstructured":"Everhart JE, Wright EC, Goodman ZD, et al. Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology 2010;51:585\u201394","journal-title":"Hepatology"},{"key":"9796_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jhep.2007.02.010","volume":"47","author":"A Lawson","year":"2007","unstructured":"Lawson A, Hagan S, Rye K, et al. The natural history of hepatitis C with severe hepatic fibrosis J Hepatol. 2007;47:37\u201345","journal-title":"J Hepatol"},{"key":"9796_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/hep.22759","volume":"49","author":"MG Ghany","year":"2009","unstructured":"Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49:1335\u201374","journal-title":"Hepatology"},{"key":"9796_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jhep.2011.02.023","volume":"55","author":"European Association for the Study of the Liver","year":"2011","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatitis C virus infection J Hepatol. 2011;55:245\u201364","journal-title":"J Hepatol"},{"key":"9796_CR5","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hep.22742","volume":"49","author":"DC Rockey","year":"2009","unstructured":"Rockey DC, Caldwell SH, Goodman ZD, et al. Liver biopsy. Hepatology 2009;49:1017\u201344","journal-title":"Hepatology"},{"key":"9796_CR6","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","volume":"97","author":"A Regev","year":"2002","unstructured":"Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97:2614\u20138","journal-title":"Am J Gastroenterol"},{"key":"9796_CR7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/00365520310000825","volume":"38","author":"I Siddique","year":"2003","unstructured":"Siddique I, El-Naga HA, Madda JP, et al. Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand J Gastroenterol 2003;38:427\u201332","journal-title":"Scand J Gastroenterol"},{"key":"9796_CR8","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.hep.2003.10.010","volume":"38","author":"PJ Scheuer","year":"2003","unstructured":"Scheuer PJ. Liver biopsy size matters in chronic hepatitis: bigger is better. Hepatology 2003;38:1356\u20138","journal-title":"Hepatology"},{"key":"9796_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jhep.2008.10.014","volume":"50","author":"P Bedossa","year":"2009","unstructured":"Bedossa P, Carrat F. Liver biopsy: the best, not the gold standard. J Hepatol 2009;50:1\u20133","journal-title":"J Hepatol"},{"key":"9796_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0399-8320(08)73990-3","volume":"32","author":"T Poynard","year":"2008","unstructured":"Poynard T, Muntenau M, Morra R, et al. Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update. Gastroenterol Clin Biol 2008;32:8\u201321","journal-title":"Gastroenterol Clin Biol"},{"key":"9796_CR11","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.hep.2003.09.022","volume":"38","author":"P Bedossa","year":"2003","unstructured":"Bedossa P, Darg\u00e8re D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449\u201357","journal-title":"Hepatology"},{"key":"9796_CR12","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/j.1572-0241.2004.30110.x","volume":"99","author":"NH Afdhal","year":"2004","unstructured":"Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004;99:1160\u201374","journal-title":"Am J Gastroenterol"},{"key":"9796_CR13","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S0168-8278(98)80134-7","volume":"29","author":"SG H\u00fcbscher","year":"1998","unstructured":"H\u00fcbscher SG. Histological grading and staging in chronic hepatitis: clinical applications and problems. J Hepatol 1998;29:1015\u201322","journal-title":"J Hepatol"},{"key":"9796_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3109\/00365528309181554","volume":"18","author":"P Schlichting","year":"1983","unstructured":"Schlichting P, H\u00f8lund B, Poulsen H. Liver biopsy in chronic aggressive hepatitis. Diagnostic reproducibility in relation to size of specimen. Scand J Gastroenterol 1983;18:27\u201332","journal-title":"Scand J Gastroenterol"},{"key":"9796_CR15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s12072-008-9114-x","volume":"3","author":"G Shiha","year":"2009","unstructured":"Shiha G, Sarin SK, Ibrahim AE, et al. Liver fibrosis: consensus recommendations of the Asian Pasific Association for the study of the liver (APASL). Hepatol Int 2009;3:323\u201333","journal-title":"Hepatol Int"},{"key":"9796_CR16","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1309\/W3XCNT4HKFBN2G0B","volume":"125","author":"E Cholongitas","year":"2006","unstructured":"Cholongitas E, Senzolo M, Standish R, et al. A systematic review of the quality of liver biopsy specimens. Am J Clin Pathol 2006;125:710\u201321","journal-title":"Am J Clin Pathol"},{"key":"9796_CR17","first-page":"103","volume":"11","author":"Y Yilmaz","year":"2011","unstructured":"Yilmaz Y, Yonal O, Kurt R, et al. Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): usefulness in patients with chronic liver disease. Hepat Mon 2011;11:103\u20136","journal-title":"Hepat Mon"},{"key":"9796_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0399-8320(08)73993-9","volume":"32","author":"V Leroy","year":"2008","unstructured":"Leroy V. Other non-invasive markers of liver fibrosis. Gastroenterol Clin Biol 2008;32:52\u20137","journal-title":"Gastroenterol Clin Biol"},{"key":"9796_CR19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/gut.2005.068585","volume":"55","author":"M Pinzani","year":"2006","unstructured":"Pinzani M. Non-invasive evaluation of hepatic fibrosis: don\u2019t count your chickens before they\u2019re hatched. Gut 2006;55:310\u20132","journal-title":"Gut"},{"key":"9796_CR20","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1111\/j.1572-0241.2001.05268.x","volume":"96","author":"A Pohl","year":"2001","unstructured":"Pohl A, Behling C, Oliver D, et al. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol 2001;96:3142\u20136","journal-title":"Am J Gastroenterol"},{"key":"9796_CR21","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.3748\/wjg.v12.i23.3682","volume":"12","author":"G Sebastiani","year":"2006","unstructured":"Sebastiani G, Alberti A. Non-invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol 2006;12:3682\u201394","journal-title":"World J Gastroenterol"},{"key":"9796_CR22","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.clinbiochem.2008.06.020","volume":"41","author":"V Leroy","year":"2008","unstructured":"Leroy V, Halfon P, Bacq Y, et al. Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: a meta-analysis with individual data. Clin Biochem 2008;41:1368\u201376","journal-title":"Clin Biochem"},{"key":"9796_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/ncpgasthep1025","volume":"5","author":"M Pinzani","year":"2008","unstructured":"Pinzani M, Vizzutti F, Arena U, Marra F. Technology insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography. Nat Clin Pract Gastroenterol Hepatol 2008;5:95\u2013106","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"9796_CR24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/hep.20772","volume":"42","author":"AS Lok","year":"2005","unstructured":"Lok AS, Ghany MG, Goodman ZD, et al. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology 2005;42:282\u201392","journal-title":"Hepatology"},{"key":"9796_CR25","first-page":"15","volume":"12","author":"RG Silva Jr","year":"2008","unstructured":"Silva RG Jr, Fakhouri R, Nascimento TV, et al. Aspartate aminotransferase-to-platelet ratio index for fibrosis and cirrhosis prediction in chronic hepatitis C patients. Braz J Infect Dis 2008;12:15\u20139","journal-title":"Braz J Infect Dis"},{"key":"9796_CR26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1665-2681(19)31836-8","volume":"7","author":"A Loaeza-del-Castillo","year":"2008","unstructured":"Loaeza-del-Castillo A, Paz-Pineda F, Oviedo-C\u00e1rdenas E, et al. AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis. Ann Hepatol 2008;7:350\u20137","journal-title":"Ann Hepatol"},{"issue":"6","key":"9796_CR27","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jhep.2010.05.035","volume":"53","author":"F Degos","year":"2010","unstructured":"Degos F, Perez P, Roche B, et al. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). J Hepatol 2010;53(6):1013\u20131021","journal-title":"J Hepatol"},{"issue":"3","key":"9796_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.hepres.2005.12.004","volume":"34","author":"AM Attallah","year":"2006","unstructured":"Attallah AM, Shiha GE, Omran MM, Zalata KR. A discriminant score based on routine laboratory blood tests for accurate diagnosis of severe fibrosis and\/or liver cirrhosis in Egyptian patients with chronic hepatitis C. Hepatol Res 2006;34(3):163\u20139","journal-title":"Hepatol Res."},{"key":"9796_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and FibroTest Hepatology. 2007;46:32\u20136","journal-title":"Hepatology"},{"key":"9796_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/hep.1840200104","volume":"20","author":"The French METAVIR Cooperative Study Group","year":"1994","unstructured":"The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994;20:15\u201320 3: 1013\u20131021.","journal-title":"Hepatology"},{"key":"9796_CR31","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3748\/wjg.v18.i8.746","volume":"18","author":"YY Hsieh","year":"2012","unstructured":"Hsieh YY, Tung SY, Lee K, et al. Routine blood tests to predict liver fibrosis in chronic hepatitis C. World J Gasroenterol 2012;18:746\u201353","journal-title":"World J Gasroenterol"},{"key":"9796_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-230X-11-44","volume":"11","author":"W Ahmed","year":"2011","unstructured":"Ahmed W, Ijaz B, Javed FT, et al. A comparison of four fibrosis indexes in chronic HCV: development of a new fibrosis-cirrhosis index (FCI). BMC Gastroenterol 2011;11:44","journal-title":"BMC Gastroenterol"},{"key":"9796_CR33","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1665-2681(19)31410-3","volume":"11","author":"TG Amorim","year":"2012","unstructured":"Amorim TG, Staub GI, Lazzarotto C, et al. Validation and comparison of simple noninvasive models for the prediction of liver fibrosis in chronic hepatitis C. Ann hepatol 2012;11:855\u201361","journal-title":"Ann hepatol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-017-9796-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-017-9796-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-017-9796-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T03:24:54Z","timestamp":1569036294000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-017-9796-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,19]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["9796"],"URL":"https:\/\/doi.org\/10.1007\/s12072-017-9796-z","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,19]]}}}